hATTR
NICE backs Akcea’s Tegsedi, pipping Alnylam to hATTR okay
Phil Taylor
Akcea, Alnylam, hATTR, market access, NICE, Rare diseases
0 Comment
X
NICE backs Akcea’s Tegsedi, pipping Alnylam to hATTR okay
https://pharmaphorum.com/news/nice-backs-akceas-tegsedi-pipping-alnylam-to-hattr-okay/